Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kappaproct added to corticosteroids for brain oedema caused by brain tumour
ISRCTN84460768Phase 2Completed
- Sponsor
- InDex Pharmaceuticals
- Start
- Nov 2009
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cobitolimod in cerebral edema, sponsored by InDex Pharmaceuticals. Primary endpoint: Brain oedema volume on MRI. Started Nov 2009; status: completed.
02
Drugs
cobitolimod
03
Conditions
cerebral edema
Beyond the preview
Go deeper on ISRCTN84460768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84460768.